Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey)

被引:78
作者
Gottlieb, S
Boyko, V
Zahger, D
Balkin, J
Hod, H
Pelled, B
Stern, S
Behar, S
机构
[1] BIKUR CHOLIM HOSP, HEIDEN DEPT CARDIOL, JERUSALEM, ISRAEL
[2] HADASSAH UNIV HOSP, DEPT MED, CORONARY CARE UNIT, IL-91240 JERUSALEM, ISRAEL
[3] SHAARE ZEDEK MED CTR, INST HEART, JERUSALEM, ISRAEL
[4] HILLEL YALFE HOSP, INST HEART, HADERA, ISRAEL
关键词
D O I
10.1016/S0735-1097(96)00334-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. This study sought to compare the relation between smoking and the 30-day and 6-month outcome after acute myocardial infarction in an Israeli nationwide survey, Background. Studies before and during the thrombolytic era reported similar or lower early mortality after acute myocardial infarction in smokers then in nonsmokers, This finding is intriguing and may be misleading because numerous epidemiologic studies have clearly shown that smoking is an independent risk factor for atherosclerosis, myocardial infarction and death, Methods. The study cohort comprised 999 consecutive patients with an acute myocardial infarction from a prospective nationwide survey conducted during January and February 1994 in all coronary cafe units operating in Israel, The prognosis of 367 patients (37%) who were smokers (current smokers and those mho smoked up to 1 month before admission) Nas compared with that of 632 nonsmokers (past smokers or those who never smoked), Results. Smokers were on average IO years younger and were more frequently men and patients with a family history of coronary heart disease and inferior infarction and less frequently patients with a previous infarction of a history of angina, hypertension and diabetes than nonsmokers, Smokers also had a lower incidence of congestive heart failure on admission or during the hospital period, Thrombolytic therapy (49% vs, 40%, p < 0.01) and aspirin (89% vs, 80%, p < 0.001) were administered more frequently in smokers than nonsmokers, The elude 30-day (6,0% vs. 15.7%) and cumulative 6-month (7.9% vs, 21.5%) mortality rates were significantly lower (p < 0.0001 for both) in smokers than nonsmokers, respectively. However, after adjustment for age, baseline characteristics, thrombolytic therapy and invasive coronary procedures, the lower 30-day (odds ratio [OR] 0.75, 95% confidence interval [CI] 0.43 to 1.29, p = 0.30) and 6-month (hazard ratio 0.84, 95% CI 0.54 to 1.30, p = 0,42) mortality rates in smokers and nonsmokers were not significantly different. The model had a power of 0.80 for OR 0.50, with alpha 0.1, Conclusions. In our nationwide survey, the seemingly better prognosis of smokers early after acute myocardial infarction was no longer evident after adjustment for baseline and clinical variables and may be explained by their younger age and a more favorable risk profile, Smokers develop acute myocardial infarction a decade earlier than nonsmokers, Efforts to lower the prevalence of smoking should continue.
引用
收藏
页码:1506 / 1513
页数:8
相关论文
共 39 条
  • [1] [Anonymous], 1990, Lancet, V335, P427
  • [2] EVALUATION OF PARADOXIC BENEFICIAL-EFFECTS OF SMOKING IN PATIENTS RECEIVING THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - MECHANISM OF THE SMOKERS PARADOX FROM THE GUSTO-I TRIAL, WITH ANGIOGRAPHIC INSIGHTS
    BARBASH, GI
    REINER, J
    WHITE, HD
    WILCOX, RG
    ARMSTRONG, PW
    SADOWSKI, Z
    MORRIS, D
    AYLWARD, P
    WOODLIEF, LH
    TOPOL, EJ
    CALIFF, RM
    ROSS, AM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (05) : 1222 - 1229
  • [3] SIGNIFICANCE OF SMOKING IN PATIENTS RECEIVING THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - EXPERIENCE GLEANED FROM THE INTERNATIONAL TISSUE PLASMINOGEN-ACTIVATOR STREPTOKINASE MORTALITY TRIAL
    BARBASH, GI
    WHITE, HD
    MODAN, M
    DIAZ, R
    HAMPTON, JR
    HEIKKILA, J
    KRISTINSSON, A
    MOULOPOULOS, S
    ERNESTO
    PAOLASSO
    VANDERWERF, T
    PEHRSSON, K
    SANDOE, E
    SIMES, J
    WILCOX, RG
    VERSTRAETE, M
    VONDERLIPPE, G
    VANDEWERF, F
    [J]. CIRCULATION, 1993, 87 (01) : 53 - 58
  • [4] PROGNOSTIC-SIGNIFICANCE OF NONFATAL MYOCARDIAL REINFARCTION
    BENHORIN, J
    MOSS, AJ
    OAKES, D
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (02) : 253 - 258
  • [5] ETIOLOGICAL AND PROGNOSTIC CORRELATES OF SITE OF MYOCARDIAL-INFARCTION
    BOURKE, S
    CONROY, RM
    MULCAHY, R
    ROBINSON, K
    [J]. EUROPEAN HEART JOURNAL, 1988, 9 (07) : 734 - 739
  • [6] CIGARETTE-SMOKING AND HEMOSTATIC FUNCTION
    FITZGERALD, GA
    OATES, JA
    NOWAK, J
    [J]. AMERICAN HEART JOURNAL, 1988, 115 (01) : 267 - 271
  • [7] PLATELET SURVIVAL AND THE DEVELOPMENT OF CORONARY-ARTERY DISEASE IN THE YOUNG-ADULT - EFFECTS OF CIGARETTE-SMOKING, STRONG FAMILY HISTORY AND MEDICAL THERAPY
    FUSTER, V
    CHESEBRO, JH
    FRYE, RL
    ELVEBACK, LR
    [J]. CIRCULATION, 1981, 63 (03) : 546 - 551
  • [8] EFFECT OF CIGARETTE-SMOKING ON CORONARY PATENCY AFTER THROMBOLYTIC THERAPY FOR MYOCARDIAL-INFARCTION
    GOMEZ, MA
    KARAGOUNIS, LA
    ALLEN, A
    ANDERSON, JL
    BROWNE, KF
    DANGOISSE, V
    LEYA, F
    LYONS, RM
    DALE, HT
    WATSON, LE
    SYMKOVIAK, GP
    FITZPATRICK, P
    HAGAN, AD
    CHRISTIE, LG
    MILLER, RH
    ASKINS, JC
    STRINGER, KA
    DAHL, CF
    HALL, SM
    ABRAMS, J
    MONRAD, ES
    BOVE, AA
    KOSINSKI, EJ
    MORCH, JE
    FALCONE, W
    BARRY, WH
    RATHBUN, JD
    SMITH, WB
    LACH, RD
    SINGH, JB
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (05) : 373 - 378
  • [9] CIGARETTE-SMOKING AND THE AGE AT ONSET OF A FIRST NONFATAL MYOCARDIAL-INFARCTION
    GOTTLIEB, S
    FALLAVOLLITA, J
    MCDERMOTT, M
    BROWN, M
    EBERLY, S
    MOSS, AJ
    [J]. CORONARY ARTERY DISEASE, 1994, 5 (08) : 687 - 694
  • [10] Gottlieb Shmuel, 1995, Am J Geriatr Cardiol, V4, P17